NY-EMPIRE-STATE-REALTY
22.3.2024 04:32:29 CET | Business Wire | Press release
The Empire State Building (ESB), in collaboration with Disney Consumer Products and Lucasfilm, today unveiled a Star Wars™-themed, villains-inspired takeover for fans in New York City that featured a dynamic light show, immersive experiences for visitors, character appearances, and participation from actor Hayden Christensen in a morning lighting ceremony. Fans who visit ESB this month will have the opportunity to immerse themselves into the Star Wars galaxy photo opportunities which feature a range of new Star Wars consumer products through April 29.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240321369670/en/
The Empire State Building Unveils Star Wars-Themed Takeover with a Dynamic Light Show, Interactive Fan Experiences, Celebrity Visit, and More (Photo: Business Wire)
"We are so pleased to unite Star Wars fans in New York City and throughout the world with this epic trip to a galaxy far, far away….,” said Jean-Yves Ghazi, president of the Empire State Building Observatory. “This one-of-a-kind takeover at the ‘World’s Most Famous Building’ allows fans to come face to face with pop culture’s most iconic villains in an authentic New York City way.”
Star Wars in Lights
This evening, a dynamic light show that featured fan-favorite scenes of Star Wars villains debuted on the building’s south side façade from 8 p.m. in continued intervals until 11 p.m. The montage was synched to the iconic “The Imperial March (Darth Vader’s Theme),” and was streamed simultaneously on iHeartRadio’s Z100 New York radio station and on the iHeartRadio app.
Star Wars actor Hayden Christensen visited the Empire State Building earlier this morning to tour the world-famous Observatory Experience and flip the ceremonial switch ahead of the dynamic light show.
Step into the Scenes
The Empire State Building’s iconic Fifth Avenue Lobby windows now feature special Star Wars-themed artistry that depicts scenes of Darth Vader, Darth Maul, and stormtroopers surrounded by a range of Star Wars merchandise, in collaboration with Disney Consumer Products and Lucasfilm. The window exhibit will remain on display until April 29.
At the base of the building, visitors can also join Hasbro and Amazon for a Star Wars fan experience on March 21-22 from 1-9 p.m. and on March 23 from 10-8 p.m. The experience highlights the villains of the Star Wars galaxy and features photo opportunities with costumed characters, which include Darth Vader and stormtroopers — as well as photo backdrops that recreate iconic scenes and locations inspired by the films like the opening hallway scene from Rogue One: A Star Wars Story, the Star Destroyer bridge, and Emperor Palpatine’s throne. Guests can also pose in the blister card packaging of a Star Wars Vintage Collection figure. Additionally, attendees will be able to check out the latest Hasbro Black Series helmets or wield their favorite character’s FX Elite or Kyber Core Lightsaber™ adult and kid collectibles.
To celebrate 25 years of the LEGO® Star Wars™ collaboration, the Empire State Building features a museum-quality display of life-sized Star Wars villains like six-foot tall brick-built recreations of Darth Vader and Darth Maul on the building’s 80th Floor. Fans also have the chance to pose with a 3D LEGO® Star Wars™ mural of Luke Skywalker and other fan-favorite characters from the film series. This exclusive LEGO® Star Wars™ exhibit will remain on display in the Observatory until April 29.
Once they reach the iconic 86th Floor Observatory, fans can pose for a photo with a life-size Darth Vader-themed POP! Figure from Funko with ESB’s unmatched New York City views as a backdrop until April 29. On March 21 and 22 from 10 a.m. to 1 p.m., Dairy Farmers of America will treat guests to samples of their new TruMoo Star Wars Blue Milk – inspired by the blue milk that made its first appearance in Star Wars: A New Hope.
“The Empire Strikes Back”
The Empire State Building Observatory will host a movie screening of Star Wars: The Empire Strikes Back on the 80th Floor on March 22. Guests who purchase tickets to the exclusive movie night will receive complimentary drinks and snacks to enjoy with the movie and access to the famed 86th and 102nd Floor Observatories. Tickets can be purchased here.
The Empire State Building Observatory recently underwent a $165 million reimagination that included the addition of a dedicated visitor entrance, an immersive museum with nine galleries, brand-new, bespoke Observatory Host uniforms, and a new 102nd Floor Observatory with unmatched views. The reimagined Observatory Experience has been voted the #1 attraction in the U.S. in Tripadvisor’s Travelers’ Choice Awards: Best of the Best for two consecutive years.
Text CONNECT to 274-16 to receive real-time information about the Empire State Building’s tower lights.
Hi-res imagery and video can be found here. More information about the Empire State Building can be found online.
Lucasfilm, the Lucasfilm logo, STAR WARS and related properties are trademarks and/or copyrights, in the United States and other countries, of Lucasfilm Ltd. and/or its affiliates. © & TM Lucasfilm Ltd.
About the Empire State Building
The Empire State Building, the “World's Most Famous Building," owned by Empire State Realty Trust, Inc. (ESRT: NYSE), soars 1,454 feet above Midtown Manhattan from base to antenna. The $165 million reimagination of the Empire State Building Observatory Experience creates an all-new experience with a dedicated guest entrance, an interactive museum with nine galleries, and a redesigned 102nd Floor Observatory with floor-to-ceiling windows. The journey to the world-famous 86th Floor Observatory, the only 360-degree, open-air observatory with views of New York and beyond, orients visitors for their entire New York City experience and covers everything from the building's iconic history to its current place in pop culture. The Empire State Building Observatory Experience welcomes millions of visitors each year and was declared "America's Favorite Building" by the American Institute of Architects, the world's most popular travel destination by Uber, the #1 attraction in the U.S. in Tripadvisor’s Travelers’ Choice Awards: Best of the Best for two consecutive years, and the #1 New York City attraction in Lonely Planet’s Ultimate Travel List.
Since 2011, the building has been fully powered by renewable wind electricity, and its many floors house a diverse array of office tenants such as LinkedIn and Shutterstock, as well as retail options like STATE Grill and Bar, Tacombi, and Starbucks. For more information and Observatory Experience tickets visit esbnyc.com or follow the building's Facebook, X (formerly Twitter), Instagram, Weibo, YouTube, or TikTok.
Source: Empire State Realty Trust
Category: Observatory
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240321369670/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom